Category: Legal News
A former associate professor at New York University, Yudong Zhu, reaches a plea deal on charges that he accepted bribes from a Chinese medical imaging company in return for details of his research.
(Reuters) — A former New York University associate professor has reached a plea deal ahead of a trial on charges that he conspired to receive bribes from a Chinese medical imaging company in exchange for information about his federally funded research.
Here's a look at some of the top legal news stories for medical device companies this week: Sales reps level $50m sex discrimination suit against Boston Scientific; Zimmer chooses new bellwethers in NexGen knee implant MDL; Boston Scientific executive's killer gets 17 years; Federal appeals court upholds Smith & Nephew's $85m win over Arthrex; Feds extend Biomet's deferred prosecution deal for another year
BioTelemetry agrees to pay more than $6 million to settle federal charges that its CardioNet subsidiary overbilled Medicare for its remote cardiac monitoring services.
BioTelemetry Inc. agreed to fork over $6.4 million to settle federal charges that its CardioNet subsidiary overbilled Medicare for unnecessary outpatient services.
Two female sales representatives for Boston Scientific's neuromodulation business file a $50 million class action lawsuit against the company for sex discrimination.
A jury clears ex-NFL great Willie Gault of the most serious charges against him, stemming from his time as co-CEO of heart monitor device company Heart Tronics/Signalife.
(Reuters) — A California jury yesterday cleared former Chicago Bears wide receiver Willie Gault of intentionally defrauding investors in a scheme to inflate the price of stock in the heart-monitoring device company Heart Tronics.
A federal appeals court upholds an $85 million patent infringement win for Smith & Nephew over Arthrex.
The U.S. Justice Dept. extends a deferred prosecution agreement with Biomet for another year, after the orthopedics company last year said it uncovered 'improprieties' by employees in Brazil and Mexico.
Biomet said yesterday that the U.S. Justice Dept. extended by a year the deferred prosecution agreement reached in 2012 over alleged violations of the Foreign Corrupt Practices Act.